Valuation
- Market cap
- 2,481,000
- Revenue TTM
- $1,730,000
- Net income TTM
- $-23,360,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -1,350.29%
- Debt to equity
- -0.31
Trading
- Volume
- 1,093,300
- Avg volume
- 10,751,814
- Day's range
- $0.17 – $0.20
- Shares out
- 13,649,000
- Stochastic %K
- 94%
- Beta
- 1.17
- Analysts
- Strong Sell
- Price target
- $9.37
Company profile
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provide...
Show more
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 512 774 8930
- Website
- https://volition.com
- Address
- 1489 West Warm Springs Road, Suite 110, Henderson, United States
Latest news
No headlines yet.
